 |
The Journal of Neuroscience, September 15, 2004, 24(37):7999-8008; doi:10.1523/JNEUROSCI.2675-04.2004
Previous Article | Next Article 
Neurobiology of Disease
Activation of the I B Kinase Complex and Nuclear Factor- B Contributes to Mutant Huntingtin Neurotoxicity
Ali Khoshnan,1
Jan Ko,1
Erin E. Watkin,1
Lisa A. Paige,2
Peter H. Reinhart,2 and
Paul H. Patterson1
1Biology Division, California Institute of Technology, Pasadena, California 91125, and 2Department of Neurobiology, Duke University Medical Center, Durham, North Carolina 27710
Transcriptional dysregulation by mutant huntingtin (Htt) protein has been implicated in the pathogenesis of Huntington's disease (HD). We find that cultured cells expressing mutant Htt and striatal cells from HD transgenic mice have elevated nuclear factor- B (NF- B) activity. Furthermore, NF- B is concentrated in the nucleus of neurons in the brains of HD transgenic mice. In inducible PC12 cells and in HD transgenic mice, mutant Htt activates the I B kinase complex (IKK), a key regulator of NF- B. Activation of IKK is likely mediated by direct interaction with mutant Htt, because the expanded polyglutamine stretch and adjacent proline-rich motifs in mutant Htt interact with IKK , a regulatory subunit of IKK. Activation of IKK may also influence the toxicity of mutant Htt, because expression of IKK promotes aggregation and nuclear localization of mutant Htt exon-1. Moreover, in acute striatal slice cultures, inhibition of IKK activity with an N-terminally truncated form of IKK blocks mutant Htt-induced toxicity in medium-sized spiny neurons (MSNs). In addition, blocking degradation of NF- B inhibitors with a dominant-negative ubiquitin ligase -transducin repeat-containing protein also reduces the toxicity of mutant Htt in MSNs. Therefore, aberrant NF- B activation may contribute to the neurodegeneration induced by mutant Htt.
Key words: Huntington's disease; IKK; polyproline; striatum; polyQ; intrabody
Received March 25, 2004;
revised July 30, 2004;
accepted July 31, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
A. L. Southwell, A. Khoshnan, D. E. Dunn, C. W. Bugg, D. C. Lo, and P. H. Patterson
Intrabodies Binding the Proline-Rich Domains of Mutant Huntingtin Increase Its Turnover and Reduce Neurotoxicity
J. Neurosci.,
September 3, 2008;
28(36):
9013 - 9020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bjorkqvist, E. J. Wild, J. Thiele, A. Silvestroni, R. Andre, N. Lahiri, E. Raibon, R. V. Lee, C. L. Benn, D. Soulet, et al.
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
J. Exp. Med.,
August 4, 2008;
205(8):
1869 - 1877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Chou, J.-Y. Weng, H.-L. Lai, F. Liao, S. H. Sun, P.-H. Tu, D. W. Dickson, and Y. Chern
Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes
J. Neurosci.,
March 26, 2008;
28(13):
3277 - 3290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yagi, C. Giallourakis, S. Mohanty, C. Scheidig, J. Shen, H. Zheng, R. J. Xavier, and A. C. Shaw
Defective signal transduction in B lymphocytes lacking presenilin proteins
PNAS,
January 22, 2008;
105(3):
979 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goswami, P. Dikshit, A. Mishra, N. Nukina, and N. R. Jana
Expression of Expanded Polyglutamine Proteins Suppresses the Activation of Transcription Factor NF{kappa}B
J. Biol. Chem.,
December 1, 2006;
281(48):
37017 - 37024.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|